Expert Dr. Salas-Whalen reveals that body composition testing, not just the number on your scale, is key to knowing whether ...

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic ...

New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing ...

Ash provides the at-home testing operational backbone for Noom’s new Proactive Health Microdose GLP-1Rx Program ...

Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

Good Laboratory Practice certification expands company's ability to support medical device manufacturers in meeting the complex demands of international regulatory frameworks "Our customers are ...

A pharmaceutical company has begun testing the first GLP-1 weight-loss therapy designed specifically for cats. The implant, called OKV-119, slowly releases medication that may curb appetite and ...

Based Probiotic Category Ahead of 2026 Weight-Loss Season - Ingredient Research, Regulatory Context, and Evidence Gaps ...

The study analyzed electronic health records from 708,406 patients diagnosed with breast cancer between January 2011 and ...

Your pet dog or cat might soon be a chubby little munchkin no more. Welcome to the burgeoning era of — we swear we’re not making this up — “ozempets,” in which your servile critters might shed some ...